An Egg White-Derived Peptide Enhances Systemic Insulin Sensitivity and Modulates Markers of Non-Alcoholic Fatty Liver Disease in Obese, Insulin Resistant Mice

Non-alcoholic fatty liver disease (NAFLD), the hepatic manifestation of the metabolic syndrome, is a global health problem. Currently, no pharmacological treatment is approved for NAFLD. Natural health products, including bioactive peptides, are potential candidates to aid in the management of metab...

Full description

Bibliographic Details
Main Authors: Stepheny C. de Campos Zani, Ren Wang, Hellen Veida-Silva, Robin D. Clugston, Jessica T. Y. Yue, Marcelo A. Mori, Jianping Wu, Catherine B. Chan
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Metabolites
Subjects:
Online Access:https://www.mdpi.com/2218-1989/13/2/174

Similar Items